Drug class
Direct-acting cholinergic agonist; parasympathomimetic muscarinic and nicotinic receptor agonist
Mechanism of action
Directly stimulates cholinergic receptors in ocular tissues, causing pupillary constriction (miosis) and contraction of the ciliary muscle. Intraocular pressure reduction is associated with increased aqueous-humour outflow; product-specific combinations may use a pinhole effect to improve near visual acuity.
General use cases
- Induction of miosis during ophthalmic surgery and reduction of intraocular pressure in selected ophthalmic indications, depending on the formulation
- In combination with brimonidine in the authorised ophthalmic product for presbyopia in adults; do not attribute the fixed-combination indication to carbachol monotherapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
